{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:49:12Z","timestamp":1792698552390,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaneurol.2019.2670","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T16:54:40Z","timestamp":1567529680000},"page":"94","source":"Crossref","is-referenced-by-count":51,"title":["Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France"],"prefix":"10.1001","volume":"77","author":[{"given":"Sandra","family":"Vukusic","sequence":"first","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, Facult\u00e9 de M\u00e9decine Lyon Est, Lyon, France"},{"name":"Service de Neurologie, Scl\u00e9rose en Plaques, Pathologies de la My\u00e9line et Neuro-Inflammation, H\u00f4pital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon\/Bron, France"},{"name":"Centre des Neurosciences de Lyon, Observatoire Fran\u00e7ais de la Scl\u00e9rose en Plaques, INSERM 1028 et CNRS UMR5292, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Rollot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, Facult\u00e9 de M\u00e9decine Lyon Est, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Hospices Civils de Lyon, Lyon, France"},{"name":"EDMUS Foundation, Lyon\/Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Casey","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, Facult\u00e9 de M\u00e9decine Lyon Est, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Hospices Civils de Lyon, Lyon, France"},{"name":"EDMUS Foundation, Lyon\/Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pique","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, Facult\u00e9 de M\u00e9decine Lyon Est, Lyon, France"},{"name":"Service de Neurologie, Scl\u00e9rose en Plaques, Pathologies de la My\u00e9line et Neuro-Inflammation, H\u00f4pital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon\/Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, Facult\u00e9 de M\u00e9decine Lyon Est, Lyon, France"},{"name":"Service de Neurologie, Scl\u00e9rose en Plaques, Pathologies de la My\u00e9line et Neuro-Inflammation, H\u00f4pital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon\/Bron, France"},{"name":"Centre des Neurosciences de Lyon, FLUID Team, INSERM 1028 et CNRS UMR5292, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Mathey","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nancy University Hospital, Nancy, France"},{"name":"Universit\u00e9 de Lorraine, EA 4360 APEMAC, Vandoeuvre-L\u00e8s-Nancy, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Edan","sequence":"additional","affiliation":[{"name":"CHU Pontchaillou, CIC1414 INSERM, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brassat","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Ruet","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Bordeaux, France"},{"name":"INSERM U1215, Neurocentre Magendie, Bordeaux, France"},{"name":"CHU de Bordeaux, CIC Bordeaux CIC1401, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"De S\u00e8ze","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Maillart","sequence":"additional","affiliation":[{"name":"Department of Neurology, Assistance Publique des H\u00f4pitaux de Paris, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Z\u00e9phir","sequence":"additional","affiliation":[{"name":"LIRIC (Lille Inflammation Research International Center), University of Lille, CHU de Lille, INSERM UMR995, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Labauge","sequence":"additional","affiliation":[{"name":"CHU de Montpellier, MS Unit, Montpellier, France"},{"name":"University of Montpellier (MUSE), Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Derache","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de la C\u00f4te de Nacre, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Frenay","sequence":"additional","affiliation":[{"name":"CHU de Nice, Universit\u00e9 Nice C\u00f4te d\u2019Azur, CRCSEP Nice, Neurologie Pasteur 2, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Moreau","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Dijon, EA4184, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Wiertlewski","sequence":"additional","affiliation":[{"name":"CHU de Nantes, Service de Neurologie, CIC015 INSERM, Nantes, France"},{"name":"INSERM CR1064, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Moisset","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neuro-Dol, CHU Clermont-Ferrand, Universit\u00e9 Clermont Auvergne, INSERM U1107, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Rico-Lamy","sequence":"additional","affiliation":[{"name":"P\u00f4le de Neurosciences Cliniques, Service de Neurologie, APHM, H\u00f4pital de la Timone, Marseille, France"},{"name":"CRMBM UMR 7339, CNRS, Aix-Marseille Universit\u00e9, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stankoff","sequence":"additional","affiliation":[{"name":"Brain and Spine Institute, Sorbonne Universit\u00e9s, UPMC Paris 06, ICM, H\u00f4pital de la Piti\u00e9 Salp\u00eatri\u00e8re, INSERM UMR S 1127, CNRS UMR 7225, Paris, France"},{"name":"Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bensa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fondation Rothschild, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thouvenot","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de N\u00eemes, N\u00eemes, France"},{"name":"Institut de G\u00e9nomique Fonctionnelle, UMR5203, INSERM 1191, Universit\u00e9 de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Heinzlef","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital de Poissy, Poissy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Khedr","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU d\u2019Amiens, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Bourre","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Rouen, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vaillant","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU Grenoble Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cabre","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de la Martinique, Fort-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Montcuquet","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Limoges, H\u00f4pital Dupuytren, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Wahab","sequence":"additional","affiliation":[{"name":"Department of Neurology, Assistance Publique des H\u00f4pitaux de Paris, H\u00f4pital Henri Mondor, Universit\u00e9 Paris Est, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Camdessanch\u00e9","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Saint-\u00c9tienne, H\u00f4pital Nord, Saint-\u00c9tienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Tourbah","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Reims, Facult\u00e9 de M\u00e9decine de Reims, URCA, Reims, France"},{"name":"LPN EA 2027 Universit\u00e9 Paris 8, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Guennoc","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Tours, H\u00f4pital Bretonneau, CRC SEP, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Hankiewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Pierre Delafontaine, Centre Hospitalier de Saint-Denis, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivania","family":"Patry","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Sud Francilien, Corbeil-Essonnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Nifle","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre Hospitalier de Versailles, Le Chesnay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Maubeuge","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Poitiers, H\u00f4pital La Mil\u00e9trie, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Labeyrie","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHU de Bic\u00eatre, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[{"name":"LIRIC (Lille Inflammation Research International Center), University of Lille, CHU de Lille, INSERM UMR995, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Axel","family":"Laplaud","sequence":"additional","affiliation":[{"name":"CHU de Nantes, Service de Neurologie, CIC015 INSERM, Nantes, France"},{"name":"INSERM CR1064, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the OFSEP Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"noi190069r1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned.","volume":"17","author":"Major","year":"2018","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi190069r2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"noi190069r3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.","volume":"354","author":"Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"noi190069r4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","article-title":"Classifying PML risk with disease modifying therapies.","volume":"12","author":"Berger","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"noi190069r5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"noi190069r6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"noi190069r7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.","volume":"354","author":"Yousry","year":"2006","journal-title":"N Engl J Med"},{"issue":"20","key":"noi190069r9","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy.","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"noi190069r10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1352458511435105","article-title":"Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.","volume":"18","author":"S\u00f8rensen","year":"2012","journal-title":"Mult Scler"},{"issue":"6","key":"noi190069r11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann Neurol"},{"issue":"10","key":"noi190069r12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1177\/1352458514531843","article-title":"Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?","volume":"20","author":"Cutter","year":"2014","journal-title":"Mult Scler"},{"issue":"11","key":"noi190069r13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(17)30282-X","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.","volume":"16","author":"Ho","year":"2017","journal-title":"Lancet Neurol"},{"issue":"11","key":"noi190069r14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1474-4422(17)30335-6","article-title":"PML risk and natalizumab: the elephant in the room.","volume":"16","author":"Derfuss","year":"2017","journal-title":"Lancet Neurol"},{"issue":"8","key":"noi190069r15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp.55.8.671","article-title":"EDMUS, a European database for multiple sclerosis.","volume":"55","author":"Confavreux","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi190069r16","article-title":"Observatoire Fran\u00e7ais de la Scl\u00e9rose en Plaques (OFSEP): a unique multimodal nationwide MS registry in France","author":"Vukusic","year":"2018","journal-title":"Mult Scler"},{"issue":"15","key":"noi190069r17","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section.","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"noi190069r19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0304-4076(90)90014-K","article-title":"Regression-based tests for overdispersion in the Poisson model.","volume":"46","author":"Cameron","year":"1990","journal-title":"J Econom"},{"issue":"6","key":"noi190069r21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s13365-016-0482-z","article-title":"Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV\u00ae DxSelect\u2122 antibody assay.","volume":"22","author":"Campagnolo","year":"2016","journal-title":"J Neurovirol"},{"issue":"6","key":"noi190069r22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13365-016-0449-0","article-title":"Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.","volume":"22","author":"Werner","year":"2016","journal-title":"J Neurovirol"},{"key":"noi190069r24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.msard.2018.06.015","article-title":"Efficacy and safety of natalizumab extended interval dosing.","volume":"24","author":"Yamout","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"noi190069r25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/ene.2016.23.issue-6","article-title":"High cumulative JC virus seroconversion rate during long-term use of natalizumab.","volume":"23","author":"Vennegoor","year":"2016","journal-title":"Eur J Neurol"},{"issue":"5","key":"noi190069r26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s13365-017-0561-9","article-title":"Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.","volume":"23","author":"Prosperini","year":"2017","journal-title":"J Neurovirol"},{"issue":"11","key":"noi190069r27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1177\/1352458513477925","article-title":"Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.","volume":"19","author":"Olsson","year":"2013","journal-title":"Mult Scler"},{"issue":"8","key":"noi190069r28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1177\/1352458518775550","article-title":"Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.","volume":"24","author":"Mills","year":"2018","journal-title":"Mult Scler"},{"key":"noi190069r20","volume-title":"Reports on Public Health and Medical Subjects","author":"Greenwood"},{"key":"noi190069r8","unstructured":"PML assessment update. https:\/\/www.biogen-international.com\/content\/corporate\/en\/medical-professionals\/dcsecure\/tysabri-update.html. Accessed July 24, 2019."},{"key":"noi190069r18","unstructured":"Institut de Veille Sanitaire, INSERM. Registres epidemiologiques et acces aux sources de donnees standardisees: etat des lieux et perspectives d\u2019amelioration [in French]. Comite National des Registres. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/Contribution_du_Comite_national_des_registres_InVs-Inserm_-propositions.pdf. Accessed July 24, 2019."},{"key":"noi190069r23","unstructured":"GiovannoniG, KapposL, BergerJ, . Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time. https:\/\/onlinelibrary.ectrims-congress.eu\/ectrims\/2018\/ectrims-2018\/228448\/gavin.giovannoni.incidence.of.natalizumab-associated.progressive.multifocal.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dgiovannoni. Accessed January 2, 2019."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2749166\/jamaneurology_vukusic_2019_oi_190069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:01:42Z","timestamp":1578913302000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2749166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.2670","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}